Birdwatch Archive

Birdwatch Note

2023-08-18 13:23:27 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

No double-blind, randomized placebo-controlled trial has ever found any benefit of using ivermectin to treat COVID-19. https://jamanetwork.com/journals/jama/fullarticle/2801827

Written by CD8A5890A799FC5B5DAA42C41B4A849A70268C37EE5928F443DAE2EB77E741B6
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1692240731413381259

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1692527629138551251
  • noteId - 1692527629138551251
  • participantId -
  • noteAuthorParticipantId - CD8A5890A799FC5B5DAA42C41B4A849A70268C37EE5928F443DAE2EB77E741B6 Participant Details
  • createdAtMillis - 1692365007085
  • tweetId - 1692240731413381259
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • No double-blind, randomized placebo-controlled trial has ever found any benefit of using ivermectin to treat COVID-19. https://jamanetwork.com/journals/jama/fullarticle/2801827

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-08-18 13:23:27 UTC
(1692365007085)
1969-12-31 23:59:59 UTC
(-1)
2023-08-20 02:11:21 UTC
(1692497481502)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-08-19 17:24:33 -0500 Rating Details
2023-08-19 16:25:58 -0500 Rating Details
2023-08-19 15:04:23 -0500 Rating Details
2023-08-19 14:51:24 -0500 Rating Details
2023-08-19 14:20:40 -0500 Rating Details
2023-08-19 12:28:43 -0500 Rating Details
2023-08-19 11:39:20 -0500 Rating Details
2023-08-19 11:37:33 -0500 Rating Details
2023-08-19 11:26:52 -0500 Rating Details
2023-08-19 10:29:23 -0500 Rating Details
2023-08-18 22:08:41 -0500 Rating Details
2023-08-18 22:00:27 -0500 Rating Details
2023-08-18 20:06:10 -0500 Rating Details
2023-08-18 19:59:36 -0500 Rating Details
2023-08-18 18:29:20 -0500 Rating Details
2023-08-18 17:28:48 -0500 Rating Details
2023-08-18 14:38:03 -0500 Rating Details
2023-08-18 13:10:03 -0500 Rating Details
2023-08-18 12:40:29 -0500 Rating Details
2023-08-18 12:21:56 -0500 Rating Details
2023-08-18 11:43:06 -0500 Rating Details
2023-08-18 11:04:22 -0500 Rating Details
2023-08-18 10:26:06 -0500 Rating Details
2023-08-18 10:08:56 -0500 Rating Details
2023-08-18 10:00:24 -0500 Rating Details
2023-08-18 09:58:03 -0500 Rating Details
2023-08-18 09:37:43 -0500 Rating Details
2023-08-18 09:33:30 -0500 Rating Details
2023-08-18 09:32:00 -0500 Rating Details
2023-08-18 08:56:03 -0500 Rating Details
2023-08-18 08:49:25 -0500 Rating Details
2023-08-18 08:47:20 -0500 Rating Details
2023-08-18 08:41:53 -0500 Rating Details
2023-08-18 08:38:10 -0500 Rating Details
2023-08-18 08:32:53 -0500 Rating Details
2023-08-18 08:30:37 -0500 Rating Details
2023-08-20 07:47:00 -0500 Rating Details
2023-08-20 03:21:29 -0500 Rating Details
2023-08-20 20:23:16 -0500 Rating Details
2023-08-21 09:03:27 -0500 Rating Details
2023-08-19 18:15:39 -0500 Rating Details
2023-08-19 02:45:24 -0500 Rating Details
2023-08-18 21:31:44 -0500 Rating Details
2023-08-18 18:29:39 -0500 Rating Details
2023-08-18 09:13:23 -0500 Rating Details
2023-08-18 08:59:07 -0500 Rating Details
2023-08-18 08:46:22 -0500 Rating Details